NASDAQ:VBIV

VBI Vaccines News Headlines

$2.71
-0.19 (-6.55 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.70
Now: $2.71
$2.88
50-Day Range
$2.74
MA: $3.16
$3.62
52-Week Range
$1.02
Now: $2.71
$6.93
Volume3.43 million shs
Average Volume6.62 million shs
Market Capitalization$688.35 million
P/E RatioN/A
Dividend YieldN/A
Beta2.14

Headlines

VBI Vaccines (NASDAQ VBIV) News Headlines Today

SourceHeadline
Zacks: Brokerages Expect VBI Vaccines Inc. (NASDAQ:VBIV) to Announce -$0.07 Earnings Per ShareZacks: Brokerages Expect VBI Vaccines Inc. (NASDAQ:VBIV) to Announce -$0.07 Earnings Per Share
americanbankingnews.com - April 18 at 2:14 AM
VBI Vaccines (NASDAQ:VBIV) Shares Gap Down to $2.89VBI Vaccines (NASDAQ:VBIV) Shares Gap Down to $2.89
americanbankingnews.com - April 17 at 8:40 AM
VBI Vaccines Announces Phase 1b/2a Data and Progress of Hepatitis B Immunotherapeutic CandidateVBI Vaccines Announces Phase 1b/2a Data and Progress of Hepatitis B Immunotherapeutic Candidate
finance.yahoo.com - April 12 at 12:40 PM
VBIV May 2021 1.500 callVBIV May 2021 1.500 call
in.finance.yahoo.com - April 8 at 12:00 PM
Dynavax (DVAX) Up on Positive COVID-19 Vaccine Study DataDynavax (DVAX) Up on Positive COVID-19 Vaccine Study Data
msn.com - April 7 at 10:56 AM
 Brokerages Expect VBI Vaccines Inc. (NASDAQ:VBIV) Will Post Quarterly Sales of $510,000.00 Brokerages Expect VBI Vaccines Inc. (NASDAQ:VBIV) Will Post Quarterly Sales of $510,000.00
americanbankingnews.com - April 2 at 3:14 AM
VBI Vaccines to Present at Oppenheimer 31st Annual Healthcare ConferenceVBI Vaccines to Present at Oppenheimer 31st Annual Healthcare Conference
finance.yahoo.com - March 15 at 12:51 PM
VBI Vaccines (VBIV) Up on Monovalent COVID-19 Vaccine StudyVBI Vaccines (VBIV) Up on Monovalent COVID-19 Vaccine Study
finance.yahoo.com - March 10 at 1:27 PM
CEPI, VBI Vaccines Collaborate To Develop COVID-19 Vaccine Candidates Against VariantsCEPI, VBI Vaccines Collaborate To Develop COVID-19 Vaccine Candidates Against Variants
finance.yahoo.com - March 10 at 1:27 PM
Coalition to fund VBI to develop vaccines against coronavirus variantsCoalition to fund VBI to develop vaccines against coronavirus variants
finance.yahoo.com - March 10 at 8:26 AM
VBI Vaccines Moves Forward With Prophylactic COVID-19 Vaccine StudyVBI Vaccines Moves Forward With Prophylactic COVID-19 Vaccine Study
finance.yahoo.com - March 9 at 2:25 PM
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
finance.yahoo.com - March 9 at 9:24 AM
VBI Vaccines Stock Could Blast Higher by 170%, Says AnalystVBI Vaccines Stock Could Blast Higher by 170%, Says Analyst
finance.yahoo.com - March 2 at 11:00 PM
VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2020, Provides Corporate Update and Outlook for 2021VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2020, Provides Corporate Update and Outlook for 2021
finance.yahoo.com - March 2 at 12:59 PM
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Lags Revenue EstimatesVBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 2 at 12:59 PM
VBI Vaccines to Present at the Raymond James 42nd Annual Institutional Investors ConferenceVBI Vaccines to Present at the Raymond James 42nd Annual Institutional Investors Conference
finance.yahoo.com - March 1 at 8:39 AM
Announcing: VBI Vaccines (NASDAQ:VBIV) Stock Increased An Energizing 148% In The Last YearAnnouncing: VBI Vaccines (NASDAQ:VBIV) Stock Increased An Energizing 148% In The Last Year
finance.yahoo.com - February 22 at 2:49 PM
VBIV Feb 2021 0.500 callVBIV Feb 2021 0.500 call
in.finance.yahoo.com - February 13 at 7:18 PM
VBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBIs 3-Antigen Prophylactic Hepatitis B VaccineVBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBI's 3-Antigen Prophylactic Hepatitis B Vaccine
benzinga.com - February 2 at 12:58 PM
VBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBI’s 3-Antigen Prophylactic Hepatitis B VaccineVBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBI’s 3-Antigen Prophylactic Hepatitis B Vaccine
finance.yahoo.com - February 2 at 12:58 PM
VBI Vaccines Announces Progress of Coronavirus Vaccine ProgramVBI Vaccines Announces Progress of Coronavirus Vaccine Program
finance.yahoo.com - January 21 at 8:10 AM
Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?
benzinga.com - January 15 at 1:44 PM
Why Novartis, BioVie, Esperion And VBI Are Moving TodayWhy Novartis, BioVie, Esperion And VBI Are Moving Today
markets.businessinsider.com - January 15 at 1:44 PM
Why VBI Vaccines Stock Is Vaulting Higher TodayWhy VBI Vaccines Stock Is Vaulting Higher Today
nasdaq.com - January 15 at 1:44 PM
VBI Vaccines Announces Publication of Results from a Phase 4 Study of VBI’s Prophylactic 3-Antigen Hepatitis B Vaccine in VaccineVBI Vaccines Announces Publication of Results from a Phase 4 Study of VBI’s Prophylactic 3-Antigen Hepatitis B Vaccine in Vaccine
finance.yahoo.com - January 15 at 8:44 AM
VBI Vaccines: Time To Meet GuidanceVBI Vaccines: Time To Meet Guidance
seekingalpha.com - January 14 at 6:16 PM
VBI Vaccines Inc.VBI Vaccines Inc.
barrons.com - January 4 at 1:09 AM
VBIV Jan 2021 7.500 callVBIV Jan 2021 7.500 call
in.finance.yahoo.com - December 25 at 11:30 PM
VBIV Jan 2021 12.500 putVBIV Jan 2021 12.500 put
in.finance.yahoo.com - December 25 at 11:30 PM
VBI Vaccines Announces European Medicines Agency Acceptance of Marketing Authorization Application (MAA) for 3-Antigen Prophylactic Hepatitis B VaccineVBI Vaccines Announces European Medicines Agency Acceptance of Marketing Authorization Application (MAA) for 3-Antigen Prophylactic Hepatitis B Vaccine
finance.yahoo.com - December 23 at 8:55 AM
Recent Challenges Demand Innovative Approaches to Surface Disinfections - MarketWatchRecent Challenges Demand Innovative Approaches to Surface Disinfections - MarketWatch
marketwatch.com - December 18 at 8:25 AM
Is VBIV A Good Stock To Buy Now?Is VBIV A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 3:36 PM
VBI Vaccines to Discuss Hepatitis B Portfolio in Virtual Fireside Chat Hosted by Raymond JamesVBI Vaccines to Discuss Hepatitis B Portfolio in Virtual Fireside Chat Hosted by Raymond James
finance.yahoo.com - December 2 at 8:13 AM
VBI Vaccines files US application for HBV vaccineVBI Vaccines files US application for HBV vaccine
seekingalpha.com - December 1 at 5:12 PM
News for VBI Vaccines IncNews for VBI Vaccines Inc
markets.businessinsider.com - November 30 at 2:22 AM
VBI Vaccines (VBIV) Early Data on HBV Candidate PositiveVBI Vaccines' (VBIV) Early Data on HBV Candidate Positive
finance.yahoo.com - November 19 at 1:57 PM
VBI Vaccines shares up 4% on positive VBI-2601 data in chronic hepatitis B virusVBI Vaccines shares up 4% on positive VBI-2601 data in chronic hepatitis B virus
seekingalpha.com - November 18 at 9:55 AM
VBI Vaccines Announces Positive Interim Phase 1b/2a Data for Hepatitis B Immunotherapeutic in Patients with Chronic InfectionVBI Vaccines Announces Positive Interim Phase 1b/2a Data for Hepatitis B Immunotherapeutic in Patients with Chronic Infection
finance.yahoo.com - November 18 at 9:55 AM
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The MarketsThe Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
benzinga.com - November 15 at 10:28 AM
VBI Vaccines Presents Phase 3 Sci-B-Vac® Data at The Liver Meeting® 2020VBI Vaccines Presents Phase 3 Sci-B-Vac® Data at The Liver Meeting® 2020
finance.yahoo.com - November 13 at 9:22 AM
What’s Next For VBI Vaccines (VBIV) Stock? Analyst Weighs InWhat’s Next For VBI Vaccines (VBIV) Stock? Analyst Weighs In
finance.yahoo.com - November 5 at 5:28 PM
Here's What Analysts Are Forecasting For VBI Vaccines Inc. (NASDAQ:VBIV) After Its Third-Quarter ResultsHere's What Analysts Are Forecasting For VBI Vaccines Inc. (NASDAQ:VBIV) After Its Third-Quarter Results
finance.yahoo.com - November 5 at 12:28 PM
VBI Vaccines Inc. (NASDAQ:VBIV) Analysts Just Slashed Next Year's Revenue Estimates By 20%VBI Vaccines Inc. (NASDAQ:VBIV) Analysts Just Slashed Next Year's Revenue Estimates By 20%
finance.yahoo.com - November 4 at 8:12 PM
Our Take On VBI Vaccines' (NASDAQ:VBIV) CEO SalaryOur Take On VBI Vaccines' (NASDAQ:VBIV) CEO Salary
finance.yahoo.com - November 4 at 8:12 PM
VBI Vaccines: A Novice In COVID-19 Vaccine Race Outshines ModernaVBI Vaccines: A Novice In COVID-19 Vaccine Race Outshines Moderna
seekingalpha.com - October 29 at 9:22 PM
INO Oct 2020 10.000 callINO Oct 2020 10.000 call
uk.finance.yahoo.com - October 29 at 6:21 AM
Beware of Investing in These 3 Small-Cap Coronavirus StocksBeware of Investing in These 3 Small-Cap Coronavirus Stocks
finance.yahoo.com - October 20 at 12:25 PM
VBI Vaccines, Inc. (VBIV) Gains But Lags Market: What You Should KnowVBI Vaccines, Inc. (VBIV) Gains But Lags Market: What You Should Know
nasdaq.com - October 9 at 11:40 PM
VBI Vaccines to Present at Upcoming Scientific ConferencesVBI Vaccines to Present at Upcoming Scientific Conferences
finance.yahoo.com - September 24 at 12:26 PM
VBI Vaccines signs agreement with Canada to develop COVID-19 vaccine by 2022VBI Vaccines signs agreement with Canada to develop COVID-19 vaccine by 2022
uk.reuters.com - September 21 at 1:21 PM
This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.